GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dis-Chem Pharmacies Ltd (JSE:DCP) » Definitions » Capex-to-Revenue

Dis-Chem Pharmacies (JSE:DCP) Capex-to-Revenue : 0.04 (As of Feb. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Dis-Chem Pharmacies Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Dis-Chem Pharmacies's Capital Expenditure for the six months ended in Feb. 2024 was R-748.43 Mil. Its Revenue for the six months ended in Feb. 2024 was R18,427.48 Mil.

Hence, Dis-Chem Pharmacies's Capex-to-Revenue for the six months ended in Feb. 2024 was 0.04.


Dis-Chem Pharmacies Capex-to-Revenue Historical Data

The historical data trend for Dis-Chem Pharmacies's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dis-Chem Pharmacies Capex-to-Revenue Chart

Dis-Chem Pharmacies Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.02 0.01 0.03 0.03

Dis-Chem Pharmacies Semi-Annual Data
Feb14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.04 0.03 0.02 0.04

Competitive Comparison of Dis-Chem Pharmacies's Capex-to-Revenue

For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dis-Chem Pharmacies's Capex-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Dis-Chem Pharmacies's Capex-to-Revenue falls into.



Dis-Chem Pharmacies Capex-to-Revenue Calculation

Dis-Chem Pharmacies's Capex-to-Revenue for the fiscal year that ended in Feb. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1027.094) / 36283.476
=0.03

Dis-Chem Pharmacies's Capex-to-Revenue for the quarter that ended in Feb. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-748.434) / 18427.477
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dis-Chem Pharmacies  (JSE:DCP) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Dis-Chem Pharmacies Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Dis-Chem Pharmacies's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Dis-Chem Pharmacies (JSE:DCP) Business Description

Traded in Other Exchanges
N/A
Address
23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceutical and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries its business operations principally in South Africa.

Dis-Chem Pharmacies (JSE:DCP) Headlines

From GuruFocus

DCP Midstream Announces Common and Preferred Unit Distributions

By Stock market mentor Stock market mentor 01-24-2023

DCP Midstream Announces Common and Preferred Unit Distributions

By GuruFocusNews GuruFocusNews 04-19-2022

4 Energy Stocks for Growth-Oriented Investors

By Alberto Abaterusso 08-19-2022

DCP Midstream Announces Increase to Common Unit Distribution

By PurpleRose PurpleRose 07-19-2022

DCP Midstream Files Form 10-K for Fiscal Year 2022

By sperokesalga sperokesalga 02-17-2023

DCP Midstream to Participate in 2022 EIC Investor Conference

By GuruFocusNews GuruFocusNews 05-19-2022

DCP Midstream to Participate in the 2022 Credit Suisse Energy Summit

By GuruFocusNews GuruFocusNews 02-23-2022